Lee Ainslie Bio Rad Laboratories, Inc. Transaction History

Maverick Capital LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $1.02 Million - $1.23 Million	2,447 Added 385.35%	3,082 $1.48 Million
Q4 2022 Feb 14, 2023	BUY	$351.71 - $456.01 $223,335 - $289,566	635 New	635 $267,000
Q3 2021 Nov 15, 2021	SELL	$657.71 - $825.77 $179,554 - $225,435	-273 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$576.64 - $649.04 $28,832 - $32,452	50 Added 22.42%	273 $176,000
Q1 2021 May 17, 2021	SELL	$547.01 - $662.35 $105,572 - $127,833	-193 Reduced 46.39%	223 $127,000
Q4 2020 Feb 16, 2021	BUY	$510.68 - $643.45 $212,442 - $267,675	416 New	416 $243,000
Q3 2020 Nov 16, 2020	SELL	$454.43 - $535.6 $415,803 - $490,074	-915 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$334.87 - $493.06 $306,406 - $451,149	915 New	915 $413,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.15B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.